Back to top
more

Alcon (ALC)

(Delayed Data from NYSE)

$73.37 USD

73.37
816,221

-0.33 (-0.45%)

Updated Aug 25, 2026 04:00 PM ET

After-Market: $73.37 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (149 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Hill-Rom (HRC) New LT Strategy Aids, Y/Y Comparisons Ail

by Zacks Equity Research

Hill-Rom's (HRC) newly initiated long-term growth strategies through fiscal 2022, focusing on all four strategic priorities, look attractive at this moment.

Zacks Equity Research

Here's Why You Should Retain Haemonetics (HAE) Stock for Now

by Zacks Equity Research

Investors are optimistic about Haemonetics (HAE) on strong demand for NexSys PCS system and potential of Hemostasis Management franchise.

Zacks Equity Research

Henry Schein (HSIC) Dental Sales Grow Globally Despite Pandemic

by Zacks Equity Research

Widespread network and channel mix along with favorable long-term trends in the dental business bode well for Henry Schein (HSIC).

Zacks Equity Research

Haemonetics (HAE) Rides on Plasma Arm Recovery Amid COVID Woes

by Zacks Equity Research

Haemonetics' (HAE) hospital business is recovering primarily driven by continued improvement in hospital procedures.

Zacks Equity Research

QIAGEN (QGEN) to Boost NeuMoDx Production With US DOD Contract

by Zacks Equity Research

QIAGEN's (QGEN) NeuMoDx platforms offer a unique combination of speed, flexibility, throughput and ease of use for molecular diagnostics testing, including laboratory-developed tests.

Zacks Equity Research

Here's Why You Should Hold on to Thermo Fisher (TMO) for Now

by Zacks Equity Research

Investors are optimistic about Thermo Fisher (TMO) on strength in end markets and raised 2021 guidance.

Zacks Equity Research

Alcon's (ALC) Robust Product Line, Market Rebound Aid Growth

by Zacks Equity Research

In Presbyopia-correcting Intraocular Lens (PCIOLs), Alcon (ALC) currently leads the market with over 55% of global share and over 80% share in the United States.

Zacks Equity Research

Illumina (ILMN) Oncology Growth Aids Amid GRAIL Merger Hurdle

by Zacks Equity Research

Illumina (ILMN) is making progress outside the United States to ensure all expecting families have access to NIPT.

Zacks Equity Research

Hologic (HOLX) Adds New Products to Omni Hysteroscopy Offering

by Zacks Equity Research

Hologic (HOLX) expands Omni suite in EMEA with the new Omni 30 degree hysteroscope, Omni Lok cervical seal and Omni 5 French seal products.

Zacks Equity Research

Thermo Fisher (TMO) Launches Kit for Safer Sample Collection

by Zacks Equity Research

Thermo Fisher (TMO) launches SpeciMAX Stabilized Saliva Collection Kit that can support global efforts toward SARS-CoV-2 research by ensuring safer saliva collection.